Literature DB >> 14652023

The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system.

Sandrine Funes1, Joseph A Hedrick, Galya Vassileva, Lisa Markowitz, Susan Abbondanzo, Andrei Golovko, Shijun Yang, Frederick J Monsma, Eric L Gustafson.   

Abstract

GPR54 is a G-protein-coupled receptor that displays a high percentage of identity in the transmembrane domains with the galanin receptors. The ligand for GPR54 has been identified as a peptide derived from the KiSS-1 gene. KiSS-1 has been shown to have anti-metastatic effects, suggesting that KiSS-1 or its receptor represents a potential therapeutic target. To further our understanding of the physiological function of this receptor, we have generated a mutant mouse line with a targeted disruption of the GPR54 receptor (GPR54 -/-). The analysis of the GPR54 mutant mice revealed developmental abnormalities of both male and female genitalia and histopathological changes in tissues which normally contain sexually dimorphic features. These data suggest a role for GPR54/KiSS-1 in normal sexual development, and indicate that study of the GPR54 mutant mice may provide valuable insights into human reproductive syndromes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652023     DOI: 10.1016/j.bbrc.2003.11.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  190 in total

Review 1.  Recent discoveries on the control of gonadotrophin-releasing hormone neurones in nonhuman primates.

Authors:  E Terasawa; J R Kurian; K A Guerriero; B P Kenealy; E D Hutz; K L Keen
Journal:  J Neuroendocrinol       Date:  2010-05-08       Impact factor: 3.627

2.  Female reproductive maturation in the absence of kisspeptin/GPR54 signaling.

Authors:  Christian Mayer; Ulrich Boehm
Journal:  Nat Neurosci       Date:  2011-04-24       Impact factor: 24.884

3.  Tacking toward reconciliation on Tacr3/TACR3 mutations.

Authors:  Robert A Steiner; Víctor M Navarro
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 4.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 5.  Organizational and activational effects of sex steroids on kisspeptin neuron development.

Authors:  Matthew C Poling; Alexander S Kauffman
Journal:  Front Neuroendocrinol       Date:  2012-06-19       Impact factor: 8.606

6.  Hypothalamic Reproductive Endocrine Pulse Generator Activity Independent of Neurokinin B and Dynorphin Signaling.

Authors:  Margaret F Lippincott; Silvia León; Yee-Ming Chan; Chrysanthi Fergani; Rajae Talbi; I Sadaf Farooqi; Christopher M Jones; Wiebke Arlt; Susan E Stewart; Trevor R Cole; Ei Terasawa; Janet E Hall; Natalie D Shaw; Victor M Navarro; Stephanie Beth Seminara
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

7.  Rbpj-κ mediated Notch signaling plays a critical role in development of hypothalamic Kisspeptin neurons.

Authors:  Matthew J Biehl; Lori T Raetzman
Journal:  Dev Biol       Date:  2015-08-28       Impact factor: 3.582

8.  Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54.

Authors:  V M Navarro; R Fernández-Fernández; J M Castellano; J Roa; A Mayen; M L Barreiro; F Gaytan; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

9.  Postnatal development of an estradiol-kisspeptin positive feedback mechanism implicated in puberty onset.

Authors:  Jenny Clarkson; Wah Chin Boon; Evan R Simpson; Allan E Herbison
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

Review 10.  Kisspeptin signaling in the brain.

Authors:  Amy E Oakley; Donald K Clifton; Robert A Steiner
Journal:  Endocr Rev       Date:  2009-09-21       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.